McGuireWoods now offers its HCPE 2026 White Paper, cataloguing investment trends across more than 20 healthcare and life‑sciences subsectors. The report spotlights behavioral health, cardiology, women’s health, revenue‑cycle management, ancillary services, and life‑science infrastructure, mapping where capital flows today. The synthesis draws from private‑equity transactions completed over the past three years, offering a granular view of deal sizes and exit multiples.

Key themes highlight AI as a value‑creation lever, the ongoing shift toward outpatient and home‑based care, and tightening regulatory and reimbursement pressures that shape deal activity. The paper argues that firms capable of integrating AI into clinical workflows can command higher valuations while navigating an increasingly complex payer landscape.

The white paper also reviews 20+ subsector investment opportunities, noting that revenue‑cycle management and ancillary services have attracted the most capital, while behavioral health remains an under‑exploited niche. Investors see the move toward home‑care as a chance to embed technology and enhance patient reach, potentially boosting return multiples.

McGuireWoods invites private‑equity professionals and healthcare operators to download the full report for deeper insights into sector dynamics and deal structuring. By understanding the evolving balance of technology, regulation, and patient demand, stakeholders can better position themselves to capture value in a rapidly shifting market.